'Hypersynchronisation' by tissue velocity imaging in patients with cardiac amyloidosis

D Bellavia
February 2009
Heart;Feb2009, Vol. 95 Issue 3, p234
Academic Journal
OBJECTIVE: It is unknown if some patients with cardiac amyloidosis (CA) have mechanical dyssynchrony, as has been demonstrated in patients with ischaemic and dilated cardiomyopathies. The aim of this study was to assess mechanical dyssynchrony in patients with CA using tissue velocity imaging (TVI) and to define its usefulness for risk stratification. DESIGN AND PATIENTS: We included 121 patients with primary amyloidosis and 37 age-matched and sex-matched controls. Patients were divided into two groups: 60 with advanced-CA and 61 with no-advanced-CA, according to left ventricular (LV) wall thickness and diastolic dysfunction. Dyssynchrony assessment included: (1) atrioventricular dyssynchrony (dys), (2) interventricular dys, (3) intraventricular dys assessed longitudinally, using the standard deviation of time to systolic peak velocity (Ts-SD) of the 12 basal and mid level LV segments, and (4) intraventricular dys assessed radially, using the difference in radial Ts between mid anteroseptal and mid posterior segments. OUTCOME: Primary end-point was all-cause death. During a median follow-up of 13 months there were 35 events among patients. RESULTS: Contrary to the hypothesis, the intraventricular dys indices in advanced-CA patients were reduced compared to either the no-advanced-CA group or to controls (Ts-SD: 12.1 (9.0); 35.1 (18.6); 24.5 (14.1), respectively, p<0.001). This reduction was primarily the result of decreased ejection time (ET). Moreover, ET was the most significant predictor of survival (HR = 0.98, p<0.001). CONCLUSIONS: The regional timing of systolic motion measured by TVI was abnormally synchronised in the patients with advanced-CA. ET reduction plays a prominent part in this process and should be considered an essential parameter for assessment of patients with cardiac amyloidosis.


Related Articles

  • Skin Involvement in Generalized Amyloidosis. Rubinow, Alan; Cohen, Alan S. // Annals of Internal Medicine;Jun78, Vol. 88 Issue 6, p781 

    Provides information on a study which examined clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis. Description of primary and multiple myeloma-associated amyloidosis; Extent of amyloid involvement in skin biopsies in primary and multiple...

  • Imaging cardiac amyloidosis: a pilot study using F-florbetapir positron emission tomography. Dorbala, Sharmila; Vangala, Divya; Semer, James; Strader, Christopher; Bruyere, John; Carli, Marcelo; Moore, Stephen; Falk, Rodney // European Journal of Nuclear Medicine & Molecular Imaging;Sep2014, Vol. 41 Issue 9, p1652 

    Purpose: Cardiac amyloidosis, a restrictive heart disease with high mortality and morbidity, is underdiagnosed due to limited targeted diagnostic imaging. The primary aim of this study was to evaluate the utility of F-florbetapir for imaging cardiac amyloidosis. Methods: We performed a pilot...

  • Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses. Almeida, M. R.; Gales, L.; Damas, A. M.; Cardoso, I.; Saraiva, M. J. // Current Drug Targets - CNS & Neurological Disorders;Oct2005, Vol. 4 Issue 5, p587 

    In transthyretin (TTR) amyloidosis TTR variants deposit as amyloid fibrils giving origin, in most cases, to peripheral polyneuropathy, cardiomyopathy, carpal tunnel syndrome and/or amyloid deposition in the eye. More than eighty TTR variants are known, most of them being pathogenic. The...

  • Typing of Amyloidosis in Renal Biopsies: Diagnostic Pitfalls. Satoskar, Anjali A.; Burdge, Kelly; Cowden, Daniel J.; Nadasdy, Gyongyi M.; Hebert, Lee A.; Nadasdy, Tibor // Archives of Pathology & Laboratory Medicine;Jun2007, Vol. 131 Issue 6, p917 

    Context.—Amyloidosis represents a group of diseases with extracellular deposition of congophilic fibrils of similar morphology but differing chemical composition. The types commonly involving the kidney are AL (light chain amyloid) and AA (serum amyloid A). Familial amyloidosis can also...

  • Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimer's APP 5'Untranslated Region. Tucker, Stephanie; Ahl, Michelle; Bush, Ashley; Westaway, David; Xudong Huang; Rogers, Jack T. // Current Alzheimer Research;Apr2005, Vol. 2 Issue 2, p249 

    A pilot study was conducted employing a well known mouse model for Alzheimer's disease to evaluate the anti-amyloid efficacy of three FDA pre-approved drugs. Paroxetine (SSRI and APP 5'UTR directed lead compound), Nacetyl cysteine (antioxidant), and erythromycin (macrolide antibiotic) were...

  • SPONTANEOUS RUPTURE OF THE LIVER IN AMYLOIDOSIS. Bujanda, Luis; Beguiristain, Adolfo; Alberdi, Fermín; Cosme, Angel; De la Hermosa, Jose Ruiz; Gutiérrez-Stampa, María A.; Arenas, Juan Ignacio // American Journal of Gastroenterology;Aug1997, Vol. 92 Issue 8, p1385 

    Hepatic rupture is an unusual complication of hepatic amyloidosis. We report the case of a 59-yr-old man with a subcapsular hematoma of the liver with hepatic rupture secondary to amyloidosis. The patient died during the surgery. The etiology, pathology, diagnosis, and treatment of this...

  • Amyloid Mimics Chronic Inflammatory Demyelinating Polyneuropathy. Rubin, Michael // Neurology Alert;Oct2011, Vol. 30 Issue 2, p10 

    Amyloidosis may present with the clinical and electrophysiologic features of chronic inflammatory demyelinating polyneuropathy. Nerve biopsy may be necessary to make an accurate diagnosis.

  • Primary nasal amyloidosis. Prasad, Devi; Somayaji, Gangadhara K. S.; Aroor, Rajeshwari; Abdulla, Mohammad N. // Internet Journal of Otorhinolaryngology;2009, Vol. 9 Issue 2, p11 

    Introduction: Amyloidosis in the head and neck is a rare but benign disease. Primary amyloidosis localized to the sinonasal tract is extremely rare. This is a report of one such case with a brief review of the literature. Case report: A 42 year old lady who presented with epistaxis and left...

  • Amyloidosis Complicating Rhinophyma Amyloidosis Complicating Rhinophyma. Nanda, V.; Garg, B.K.; Chittoria, R.; Biswas, G.; Sharma, R.K. // Aesthetic Plastic Surgery;Mar/Apr2004, Vol. 28 Issue 2, p98 

    Rhinophyma is the advanced stage of acne rosacea and a source of embarrassment for the patient. Secondary localized cutaneous amyloidosis complicating rhinophyma is not reported in the literature. A patient with rhinophyma was treated by excision and primary closure. The histologic examination...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics